Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.

Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
复制标题

DOI:
10.18632/oncotarget.17309
复制
发表时间:
2017-06-27
期刊:
影响因子:
--
通讯作者:
Zhuge X
Zhuge X
中科院分区:
其他
文献类型:
--
作者:
Guo C;Chen X;Wang Z;Xiao W;Wang Q;Sun K;Zhuge X

文献摘要

参考文献

被引文献

相似文献

胰腺神经内分泌癌(PNEC)常被误诊为胰腺导管腺癌(PDAC)。这项回顾性研究使用磁共振成像(MRI)(包括对比增强(CE)和弥散加权成像(DWI))区分PNEC和PDAC。比较37例PDAC和13例PNEC的临床数据和MRI表现,包括T1/T2信号、肿瘤边界、大小、强化程度和表观扩散系数(ADC)。PDAC中边界的定义比PNEC更差(97.3% vs. 61.5%,p<0.01)。PNEC中动脉期(38.5% vs. 0.0)、门脉期(46.2% vs. 2.7%)和延迟期(46.2% vs. 5.4%)的高/等信号比PDAC更常见(均p<0.01)。淋巴结转移(97.3% vs.61.5%,p<0.01)和局部浸润/远处转移(86.5% vs.46.2%,p<0.01)在PDAC中较PNEC多见。在动脉期和门脉期,PNEC的CE-MRI增强程度高于PDAC(p<0.01)。PNEC的ADC值明显低于正常胰腺组织(p<0.01)和PDAC(p<0.01)。动脉期及门脉期信号强度比和ADC值显示出最大的受试者工作特征曲线下面积,并具有良好的敏感性(92.1%~ 97.2%)和特异性(76.9%~ 92.3%)。因此,动脉期、门脉期强化程度及ADC值可作为MRI鉴别PNEC与PDAC的依据。
Pancreatic neuroendocrine carcinoma (PNEC) is often misdiagnosed as pancreatic ductal adenocarcinoma (PDAC). This retrospective study differentiated PNEC from PDAC using magnetic resonance imaging (MRI), including contrast-enhanced (CE) and diffusion-weighted imaging (DWI). Clinical data and MRI findings, including the T1/T2 signal, tumor boundary, size, enhancement degree, and apparent diffusion coefficient (ADC), were compared between 37 PDACs and 13 PNECs. Boundaries were more poorly defined in PDAC than PNEC (97.3% vs. 61.5%, p<0.01). Hyper-/isointensity was more common in PNEC than PDAC at the arterial (38.5% vs. 0.0), portal (46.2% vs. 2.7%) and delayed phases (46.2% vs. 5.4%) (all p<0.01). Lymph node metastasis (97.3% vs. 61.5%, p<0.01) and local invasion/distant metastasis (86.5% vs. 46.2%, p<0.01) were more common in PDAC than PNEC. Enhancement degree via CE-MRI was higher in PNEC than PDAC at the arterial and portal phases (p<0.01). PNEC ADC values were lower than those of normal pancreatic parenchyma (p<0.01) and PDAC (p<0.01). Arterial and portal phase signal intensity ratios and ADC values showed the largest areas under the receiver operating characteristic curve and good sensitivities (92.1%–97.2%) and specificities (76.9%–92.3%) for differentiating PNEC from PDAC. Thus the enhancement degree at the arterial and portal phases and the ADC values may be useful for differentiating PNEC from PDAC using MRI.
DOI: 10.1007/s00330-014-3532-z
发表时间: 2015-03-01
期刊: EUROPEAN RADIOLOGY
影响因子: 5.9
作者:
Kim, Dong Wook;Kim, Hyoung Jung;Hong, Seung-Mo
通讯作者: Hong, Seung-Mo
DOI: 10.1002/cncr.23549
发表时间: 2008-07-15
期刊: CANCER
影响因子: 6.2
作者:
Pape, Ulrich-Frank;Jann, Henning;Wiedenmann, Bertram
通讯作者: Wiedenmann, Bertram
DOI: 10.1007/s00330-009-1422-6
发表时间: 2009-10-01
期刊: EUROPEAN RADIOLOGY
影响因子: 5.9
作者:
Ahn, Sung Soo;Kim, Myeong-Jin;Lim, Joon Seok
通讯作者: Lim, Joon Seok
DOI: 10.1159/000452279
发表时间: 2017-01-01
期刊: ONCOLOGY
影响因子: 3.5
作者:
Gilabert, Marine;Rho, Young Soo;Kavan, Petr
通讯作者: Kavan, Petr
DOI: 10.1002/nbm.3669
发表时间: 2017-01-01
期刊: NMR IN BIOMEDICINE
影响因子: 2.9
作者:
Becker, Anton S.;Wagner, Matthias W.;Boss, Andreas
通讯作者: Boss, Andreas